The global colposcopy market size was US$ 455 billion in 2021. The global colposcopy market size is forecast to reach US$ 711 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2022 to 2030.
Colposcopy is a procedure for detecting malignant or potentially cancerous cells in the cervix, vaginal canal, or vulva. The test evaluates whether the cells in the cervix are aberrant and whether they need to be removed through treatment. Specialized equipment called a colposcope is used to perform this minimally invasive surgery. A speculum is inserted into the vagina to split the walls and allow the medical expert to see the cervix clearly. A tissue sample may be taken for laboratory testing if any abnormalities or an uncommon region of cells are discovered during the operation. A biopsy is a medical term for this technique.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The epidemic of COVID-19 has put huge pressure on the healthcare sector. This resulted in delays in the start and finish of cancer treatment. Patient access to and attendance at outpatient medical visits, including preventive treatments like cervical cancer screening, was restricted in many nations. Furthermore, the pandemic has impacted all aspects of cancer care and research, with cancer screening and treatment being categorized as a low-priority service in a number of countries around the world. As a result, the pandemic had a substantial influence on the broader industry, resulting in a significant drop in income generation.
Regional Analysis
North America accounted for the major market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the availability of technologically advanced screening tools, the increasing prevalence of cervical cancer, and rising government initiatives.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the existence of a huge patient population, increasing demand for technically advanced and cost-effective healthcare systems.
Leading Competitors
The leading prominent companies profiled in the global colposcopy market are:
Scope of the Report
The global colposcopy market segmentation focuses on Product Type, Portability, Application, End-Use, and Region.
Segmentation based on Product Type
Segmentation based on Portability
Segmentation based on Application
Segmentation based on End-Use
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL COLPOSCOPY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL COLPOSCOPY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL COLPOSCOPY MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 DIGITAL
5.3 OPTICAL
6 GLOBAL COLPOSCOPY MARKET, BY PORTABILITY
6.1 OVERVIEW
6.2 HANDHELD
6.3 PORTABLE
6.4 STATIONARY
7 GLOBAL COLPOSCOPY MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 ORAL
7.3 PELVIC
8 GLOBAL COLPOSCOPY MARKET, BY END-USE
8.1 OVERVIEW
8.2 HOSPITAL
8.3 AMBULATORY SURGICAL CENTERS
8.4 GYNAECOLOGY CLINICS
8.5 DIAGNOSTIC CENTERS
8.6 SPECIALTY CLINICS
8.7 RESEARCH AND ACADEMICS
9 GLOBAL COLPOSCOPY MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL COLPOSCOPY MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
11 COMPANY PROFILES
11.1 ATMOS MEDIZIN TECHNIK GMBH & CO. KG
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 CARL ZEISS MEDITEC AG
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 COOPERSURGICAL, INCORPORATED
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 ECLERIS
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 DYSIS MEDICAL INCORPORATED
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 KAPS GMBH & CO. KG
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.7 MCKESSON MEDICAL-SURGICAL INCORPORATED
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.8. OPTOMIC
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.9 OLYMPUS CORPORATION
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.10 SEILER INSTRUMENT INCORPORATED
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved